|
|
Article: Eli Lilly and Company Unveils Global Partnership to Battle One of the Deadliest International Public Health Threats; $70 Million Initiative is First of its Kind, Comprehensive Effort to Fight Spread of Multi-Drug Resistant Tuberculosis.
- Article from:
- PR Newswire
- Article date:
- June 5, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GENEVA -- GENEVA, June 5 /PRNewswire/ -- Eli Lilly and Company today unveiled a global effort with the World Health Organization (WHO), the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC), Brigham and Women's Hospital (BWH), an affiliate of Harvard Medical School, and Purdue University to increase the number of trained personnel and drugs available to treat the expanding crisis of Multi-Drug Resistant Tuberculosis (MDR-TB).
As part of this pioneering effort, Lilly will:
* Transfer its technology to manufacture two antibiotics necessary for
treatment of MDR-TB to nations where the disease is most prevalent;
...